BridgeMD
New treatment option for Hypoxic Ischemic Encephalopathy of Newborn
Official title Continuous Glucose Monitoring in HIE
ClinicalTrials.gov ID: NCT06563687
What this study is testing
- What it's testing
- The aim of the study is to examine whether the use of continuous glucose monitoring (CGM) to guide the clinical management of glycaemic control will result into an increased time in the target glucose concentration. To further examine the efficacy of using CGM the following secondary outcomes in the two groups were assessed: mean glucose values, glucose variability within individuals, percentage of time that glucose values are in hyperglycaemic or hypoglycaemic ranges.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 6
You may be able to join if
- Birth weight \>1.8kg
- Gestation \>35 weeks
- Aged \<6hours
- Moderate or severe HIE following perinatal asphyxia
You likely can't join if
- Major congenital malformations
- Inborn errors of metabolism,
- Congenital infections
- Imminent death
The study team makes the final eligibility decision.
Where it's taking place
- Avellino, Italy
- Naples, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, up to 6 hours. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Avellino, Italy; Naples, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.